Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen.

被引：0
|
作者：
Garber, JE
Halabi, S
Kaplan, E
Edge, S
Dressler, L
Paskett, E
Berliner, N
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Duke Univ, Durham, NC 27706 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] Yale Univ, Sch Med, New Haven, CT 06520 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6S / 6S
页数：1
相关论文
共 50 条
  • [41] Prevalence of inherited and acquired risk factors for venous thromboembolic (VTE) disease among women with breast cancer taking adjuvant tamoxifen (TAM).
    Molica, S
    Battaglia, C
    Santoro, R
    Mirabelli, R
    Squillace, R
    Iannaccaro, P
    Iuliano, F
    Muleo, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 77S - 77S
  • [42] 10 year event-free survival (EFS) in postmenopausal women with early stage breast cancer during the second five years after adjuvant tamoxifen.
    Kennecke, H
    Speers, C
    Chia, S
    Norris, B
    Gelmon, K
    Bryce, C
    Barnett, J
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S57 - S58
  • [43] Prevalence of Factor V Leiden (FVL, G1691A) and F-II (G20210A) Mutations in Jordanian Atherosclerotic Patients
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2023, 17 : 189 - 193
  • [44] Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
    Romero, Sally A. D.
    Young, Katie
    Hickey, Martha
    Su, H. Irene
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (12):
  • [45] Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer
    Zidan, J
    Rubenstein, W
    ONCOLOGY, 1999, 56 (01) : 43 - 45
  • [46] Survival with adjuvant surgical oophorectomy and tamoxifen in premenopausal women with operable breast cancer
    Love, R. R.
    Dinh, N. V.
    Quy, T. T.
    Linh, N. D.
    Hade, E. M.
    Young, G. S.
    Jarjoura, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Dubsky, Peter
    Jakesz, Raimund
    Singer, Christian F.
    Kemmerling, Ralf
    Greil, Richard
    Jelen, Andrea
    Boehm, Gerhard
    Jasarevic, Zerina
    Haid, Anton
    Gruber, Christine
    Poestlberger, Sabine
    Filipits, Martin
    Gnant, Michael
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7828 - 7834
  • [48] Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
    Dominick, Sally
    Hickey, Martha
    Chin, Jason
    Su, H. Irene
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (12):
  • [49] Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen
    KalefEzra, JA
    Pavlidis, N
    Klouvas, G
    Karantanas, A
    Hatzikonstantinou, I
    Glaros, D
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (02) : 161 - 168
  • [50] Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
    Chin, Jason
    Konje, Justin C.
    Hickey, Martha
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
12345